The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 28.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM & Award of Executive Share Options

20 Sep 2023 15:20

RNS Number : 1099N
Ilika plc
20 September 2023
 

 

Ilika plc

("Ilika", the "Group". or the "Company")

 

Result of AGM & Award of Executive Share Options

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.

 

All resolutions were passed with the results of the proxy voting for the AGM are set out below:

 

Resolution

Total votes For

% of votes cast

Total votes Against

% of votes cast

Votes Withheld

1. To receive and adopt the audited accounts of the Company for the financial year ended 30 April 2023, together with the Directors' and Auditor's Reports in respect of such accounts

78,094,120

99.75%

59,223

0.08%

134,987

2. To re-elect Graeme Purdy as a director of the Company who retires by rotation in accordance with Article 111 of the Company's articles of association

77,741,492

99.30%

403,569

0.52%

143,269

3. To elect Jason Stewart as a director of the Company.

77,992,559

99.62%

131,147

0.17%

164,624

4. To re-appoint BDO LLP as auditors to the Company, to hold office until the conclusion of the next general meeting at which accounts are laid before the Company, and to authorise the directors to determine their remuneration

77,909,807

99.52%

77,981

0.10%

300,542

5. Allotment of shares

77,642,665

99.18%

495,600

0.63%

150,065

6. Special resolution: Allotment of equity securities

77,426,002

98.90%

634,239

0.81%

228,089

 

Grant of Options

 

The Company also announces that on 20 September 2023 it granted nominal value options over 146,804 ordinary shares of 1p each in the Company ("Ordinary Shares") to Executive Directors under the Company's Bonus Scheme. 

 

The options granted represent in aggregate 0.09 per cent of the Company's existing issued ordinary share capital.

 

The options were awarded as part of the Company's Bonus Scheme where 50% is payable as cash and 50% is deferred into options for one year, subject to continued employment.

 

Director /

PDMR

Number of options granted

Total number of Options

held post grant

Percent of current issued

share capital (%)

Graeme Purdy

131,005

2,304,058

1.45

Jason Stewart

15,799

315,799

0.20

 

Graeme Purdy, CEO, holds 782,927 Ordinary shares representing 0.49% of current issued share capital. Jason Stewart, CFO, does not currently hold any Ordinary shares.

 

 

 

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR

Liberum Capital Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber,

Nikhil Varghese

Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Matthew Armitt, Mark Whitmore, Detlir Elezi,

Natasha Ninkov

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Lianne Applegarth

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

Tom Cooper

Mob: 07971 221 972

 

About Ilika plc

Ilika specialises in the development of solid-state batteries. Its Stereax® product line is designed for miniature medical devices and specialist internet of Things (IoT) applications. Stereax® enables disruptive product designers looking for an intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to ICs. For more information about Ilika, please visit:  https://www.ilika.com.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Graeme Purdy

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Ilika plc

 

b)

 

LEI

 

 

213800TMDNIE3Z8XXD26

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each

Identification code

GB00B608Z994

b)

 

Nature of the transaction

 

 

Grant of share options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1p

131,005

d)

 

Aggregated information

Not Applicable - Single Transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

19 September 2023

f)

 

Place of the transaction

 

 

Off market

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jason Stewart

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Ilika plc

 

b)

 

LEI

 

 

213800TMDNIE3Z8XXD26

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each

Identification code

GB00B608Z994

b)

 

Nature of the transaction

 

 

Grant of share options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1p

15,799

d)

 

Aggregated information

Not Applicable - Single Transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

19 September 2023

f)

 

Place of the transaction

 

 

Off market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGMZGZLDGFGFZM
Date   Source Headline
17th Sep 20134:09 pmRNSResult of AGM
17th Sep 20137:00 amRNSAGM Statement
16th Sep 20137:00 amRNSTwo New Customers in Europe
23rd Aug 20131:25 pmRNSPosting of Annual Report & Notice of AGM
2nd Aug 20135:02 pmRNSConversion of Securities
30th Jul 20137:00 amRNSContract Renewals and Grant Award
19th Jul 20132:50 pmRNSHolding(s) in Company
19th Jul 201311:17 amRNSHolding(s) in Company
18th Jul 20137:00 amRNS£3.3 million EPSRC Grant Award to Southampton Univ
15th Jul 20137:00 amRNSFinal Results
21st May 20131:09 pmRNSHolding(s) in Company
20th May 20137:00 amRNSDirectorate Change and Conversion of Securities
17th May 20133:57 pmRNSPlacing - Replacement
17th May 20137:00 amRNSPlacing
1st May 20137:00 amRNSFuel Cell Catalyst Patent Granted in Japan
22nd Apr 20137:00 amRNSContract with new European Customer
16th Apr 20137:00 amRNSTrading Update
21st Feb 20137:00 amRNSRenewal of Contract
29th Jan 20137:00 amRNSCompletion of Laboratory Facility Expansion
18th Jan 20133:28 pmRNSHolding(s) in Company
17th Jan 20135:46 pmRNSHolding(s) in Company
17th Jan 201311:16 amRNSHolding(s) in Company
15th Jan 20135:21 pmRNSHolding(s) in Company
10th Jan 20137:00 amRNSInterim Results
21st Dec 20127:00 amRNSGrant of Fuel Cell Catalyst Patent
18th Dec 20121:41 pmRNSCompletion of Disposal
17th Dec 20127:00 amRNSConversion of Securities
11th Dec 20127:00 amRNSRenewal of Contract
29th Nov 20124:44 pmRNSHolding(s) in Company
28th Nov 20125:00 pmRNSHolding(s) in Company
27th Nov 20122:18 pmRNSHolding(s) in Company
19th Nov 20127:00 amRNSEnergizer Relationship Update
22nd Oct 20127:00 amRNSTrading Update
5th Oct 20127:00 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSTotal Voting Rights
18th Sep 20127:00 amRNSDiscontinuing of wound care products and services
14th Sep 20127:00 amRNSCarbon Trust Investment
7th Sep 20121:27 pmRNSResult of AGM
7th Sep 20127:00 amRNSAGM Statement
9th Aug 20127:00 amRNSPosting of Annual Report & Notice of AGM
19th Jul 20127:00 amRNSFinal Results
14th Jun 20127:14 amRNSChange of Adviser
1st Jun 201210:01 amRNSTotal Voting Rights
18th May 20127:00 amRNSTrading Update
17th May 20127:00 amRNSConversion of Securities
2nd May 20127:00 amRNSVapour Deposition Method US Patent Grant
1st May 20123:00 pmRNSHolding(s) in Company
30th Apr 201210:27 amRNSDirector's Dealings
30th Apr 201210:22 amRNSTotal Voting Rights
25th Apr 20122:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.